NEW YORK, July 11, 2023 /PRNewswire/ — The Klein Law Firm announces that it is investigating allegations that Regeneron Pharmaceuticals, Inc. (“Regeneron”) (NASDAQ: REGN) violated federal securities laws. CURRENT INVESTIGATION DETAILS:The investigation focuses on whether the Company…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.